Avenir Corporation’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $890K | Hold |
76,365
| – | – | 0.09% | 43 |
|
|
2025
Q1 | $567K | Hold |
76,365
| – | – | 0.06% | 48 |
|
|
2024
Q4 | $458K | Hold |
76,365
| – | – | 0.05% | 51 |
|
|
2024
Q3 | $391K | Hold |
76,365
| – | – | 0.04% | 54 |
|
|
2024
Q2 | $276K | Buy |
76,365
+10,000
| +15% | +$36.2K | 0.03% | 60 |
|
|
2024
Q1 | $213K | Hold |
66,365
| – | – | 0.02% | 64 |
|
|
2023
Q4 | $325K | Buy |
66,365
+35,800
| +117% | +$175K | 0.03% | 56 |
|
|
2023
Q3 | $167K | Hold |
30,565
| – | – | 0.02% | 59 |
|
|
2023
Q2 | $205K | Sell |
30,565
-85
| -0.3% | -$570 | 0.02% | 59 |
|
|
2023
Q1 | $271K | Hold |
30,650
| – | – | 0.03% | 55 |
|
|
2022
Q4 | $234K | Hold |
30,650
| – | – | 0.02% | 59 |
|
|
2022
Q3 | $218K | Sell |
30,650
-23,450
| -43% | -$167K | 0.02% | 57 |
|
|
2022
Q2 | $438K | Buy |
54,100
+25,100
| +87% | +$203K | 0.04% | 48 |
|
|
2022
Q1 | $403K | Buy |
29,000
+1,000
| +4% | +$13.9K | 0.03% | 51 |
|
|
2021
Q4 | $786K | Hold |
28,000
| – | – | 0.06% | 44 |
|
|
2021
Q3 | $952K | Hold |
28,000
| – | – | 0.08% | 45 |
|
|
2021
Q2 | $1.14M | Hold |
28,000
| – | – | 0.09% | 43 |
|
|
2021
Q1 | $1.13M | Hold |
28,000
| – | – | 0.1% | 45 |
|
|
2020
Q4 | $1.66M | Hold |
28,000
| – | – | 0.16% | 37 |
|
|
2020
Q3 | $1.36M | Hold |
28,000
| – | – | 0.14% | 39 |
|
|
2020
Q2 | $1.36M | Buy |
+28,000
| New | +$1.36M | 0.15% | 39 |
|